Mitochondrial Inhibitors and Neurodegenerative Disorders
Mihondria have long been the Rodney Dangerfield of cellular organelles. Believed to be the remnants of bacterial infection of eukaryotic cells eons ago, the mihondrion evolved a symbiotic relationship in which it dutifully served as the efficient source of A TP for cell function. The extraordinary dependence of cells on the energy provided by mito­ chondrial oxidative metabolism of glucose, especially through critical organs such as the heart and brain, is underlined by the fatal consequences of toxins that interfere with the mihondrial electron transport system. Consistent with their ancestry, the mihondria have their own DNA that encodes many but not all of their proteins. The mihon­ dria and their genes come from the mother via the ovum since sperm do not possess mihondria. This extranuclear form of inheritance derived exclusively from the female side has proven to be a powerful tool for tracing the evolution by the number of base substitutions in mtDNA. That mihondrial gene mutations might be a source of human dis­ ease became evident a decade ago with the characterization of a group of multisystem disorders, typically involving the nervous system, which are transmitted from mother to child. Specific point mutations in mtDNA have been associated with the different syndromes.
1101313702
Mitochondrial Inhibitors and Neurodegenerative Disorders
Mihondria have long been the Rodney Dangerfield of cellular organelles. Believed to be the remnants of bacterial infection of eukaryotic cells eons ago, the mihondrion evolved a symbiotic relationship in which it dutifully served as the efficient source of A TP for cell function. The extraordinary dependence of cells on the energy provided by mito­ chondrial oxidative metabolism of glucose, especially through critical organs such as the heart and brain, is underlined by the fatal consequences of toxins that interfere with the mihondrial electron transport system. Consistent with their ancestry, the mihondria have their own DNA that encodes many but not all of their proteins. The mihon­ dria and their genes come from the mother via the ovum since sperm do not possess mihondria. This extranuclear form of inheritance derived exclusively from the female side has proven to be a powerful tool for tracing the evolution by the number of base substitutions in mtDNA. That mihondrial gene mutations might be a source of human dis­ ease became evident a decade ago with the characterization of a group of multisystem disorders, typically involving the nervous system, which are transmitted from mother to child. Specific point mutations in mtDNA have been associated with the different syndromes.
169.99 Out Of Stock
Mitochondrial Inhibitors and Neurodegenerative Disorders

Mitochondrial Inhibitors and Neurodegenerative Disorders

Mitochondrial Inhibitors and Neurodegenerative Disorders

Mitochondrial Inhibitors and Neurodegenerative Disorders

Hardcover(2000)

$169.99 
  • SHIP THIS ITEM
    Temporarily Out of Stock Online
  • PICK UP IN STORE

    Your local store may have stock of this item.

Related collections and offers


Overview

Mihondria have long been the Rodney Dangerfield of cellular organelles. Believed to be the remnants of bacterial infection of eukaryotic cells eons ago, the mihondrion evolved a symbiotic relationship in which it dutifully served as the efficient source of A TP for cell function. The extraordinary dependence of cells on the energy provided by mito­ chondrial oxidative metabolism of glucose, especially through critical organs such as the heart and brain, is underlined by the fatal consequences of toxins that interfere with the mihondrial electron transport system. Consistent with their ancestry, the mihondria have their own DNA that encodes many but not all of their proteins. The mihon­ dria and their genes come from the mother via the ovum since sperm do not possess mihondria. This extranuclear form of inheritance derived exclusively from the female side has proven to be a powerful tool for tracing the evolution by the number of base substitutions in mtDNA. That mihondrial gene mutations might be a source of human dis­ ease became evident a decade ago with the characterization of a group of multisystem disorders, typically involving the nervous system, which are transmitted from mother to child. Specific point mutations in mtDNA have been associated with the different syndromes.

Product Details

ISBN-13: 9780896038059
Publisher: Springer-Verlag New York, LLC
Publication date: 10/01/1999
Series: Contemporary Neuroscience
Edition description: 2000
Pages: 314
Product dimensions: 6.10(w) x 9.25(h) x 0.03(d)

Table of Contents

I. Mihondrial Toxins: Symptomatology, Origin, and Chemistry.- 1 • Clinical Manifestations and Mechanisms of Action of Environmental Mihondrial Toxins.- 2 • History of 3-Nitropropionic Acid: Occurrence and Role in Human and Animal Disease.- 3 • The Neurochemistry of 3-Nitropropionic Acid.- II. Mihondrial Dysfunctions: Models of Neurodegeneration and Mechanisms of Action.- 4 • In Vitro Studies of 3-Nitropropionic Acid.- 5 • Cognitive and Motor Deficits Produced by Acute and Chronic Administration of 3-Nitropropionic Acid in Rats.- 6 • Comparative Study on 3-Nitropropionic Acid Neurotoxicity.- 7 • Mechanisms of 3-Nitropropionic Acid Neurotoxicity.- 8 • Gender-Related Difference of the Effect of 3-Nitropropionic Acid on Striatal Artery.- 9 • Variable Susceptibility to Neurotoxicity of Systemic 3-Nitropropionic Acid.- 10 • The 3-Nitropropionic Acid Model of Huntington’s Disease: Do Alterations in the Expression of Metabolic mRNAs Predict the Development of Striatal Pathology?.- 11 • Mechanisms of Action of 3-Nitropropionic Acid: Dopamine Overflow and Vulnerability of the Lateral Striatal Artery.- 12 • Mihondrial Inhibition and Neuronal Death in Huntington’s Disease.- 13 • Effects of Brain Mihondrial Metabolism, Aging, and Caloric Restriction on Membrance Lipids and Proteins: An Electron Paramagnetic Resonance Investigation.- 14 • Malonate: Profile and Mechanisms of Striatal Toxicity.- 15 • Malonic Acid and the Chronic Administration Model of Excitotoxicity.- 16 • Sodium Azide-Induced Neurotoxicity.- III. Treatment Interventions for Mihondrial-Induced Neurotoxicity.- 17 • Neuroprotective Strategies Against Cellular Hypoxia.- 18 • Neuroprotective Effect of Perinatal Hypoxia Against 3-Nitropropionic Acid Neurotoxicity.-19 • Neural Transplantation and Huntington’s Disease: What Can We Learn from the 3-Nitropropionic Acid Model?.- 20 • Neuroprotective Strategies in Parkinson’s Disease and Huntington’s Chorea: MPTP- and 3-NPA-Induced Neurodegeneration as Models.
From the B&N Reads Blog

Customer Reviews